-+ 0.00%
-+ 0.00%
-+ 0.00%

Nanjing Xinbai (600682.SH) plans to sell shares in two overseas holding subsidiaries at a price of about 900 million yuan

Zhitongcaijing·11/17/2026 14:01:16
Listen to the news

Zhitong Finance App News, Nanjing Xinbai (600682.SH) announced that the company plans to sell 100% of the shares of AS Nursing and AS One, a wholly owned subsidiary of Natali Healthcare in Israel, to Danel, an Israeli listed company, to optimize the business structure, improve asset operation efficiency while quickly returning capital, and accelerate the implementation of a strategic development plan to gradually expand the European and particularly British domestic pension market through epitaxial mergers and acquisitions.

After the transaction is completed, the company will no longer hold shares in AS Nursing and AS One, and the above two companies will no longer be included in the scope of the company's consolidated statements. The underlying equity value of the transaction was NIS 410 million (equivalent to approximately RMB 900 million, at the exchange rate of September 30, 2026). As of September 30, 2026, the book cost for long-term equity investment corresponding to 100% equity in AS Nursing at the NataliHealthcare individual statement level was 133.0 million NIS (equivalent to approximately RMB 2920.95 million), and the book cost for long-term equity investment corresponding to 100% equity in AS One was 10,000 NIS (equivalent to approximately RMB 0.22 million). The total price of this transaction is a premium of RMB 608 million over the book value.

The sale of assets is an optimization adjustment of the company's current nursing business layout in Israel. It does not mean that the company has completely withdrawn from the Israeli pension health service market. After the transaction is completed, the company will continue to maintain private payment businesses (accounting for about 20% of revenue) and small-scale government businesses. Subsequent companies will carefully evaluate other high-quality pension health service projects in the Israeli market based on the local market environment, regulatory requirements and potential investment opportunities.